The estimated Net Worth of C Raymond Jr Larkin is at least $19.2 Milión dollars as of 15 August 2024. Mr. Larkin owns over 6,500 units of Align Technology stock worth over $6,359,812 and over the last 21 years he sold ALGN stock worth over $12,302,241. In addition, he makes $499,972 as Independent Chairman of the Board at Align Technology.
Charles has made over 28 trades of the Align Technology stock since 2003, according to the Form 4 filled with the SEC. Most recently he bought 6,500 units of ALGN stock worth $1,529,645 on 15 August 2024.
The largest trade he's ever made was exercising 75,000 units of Align Technology stock on 8 May 2012 worth over $1,376,250. On average, Charles trades about 4,206 units every 93 days since 2003. As of 15 August 2024 he still owns at least 28,247 units of Align Technology stock.
You can see the complete history of Mr. Larkin stock trades at the bottom of the page.
Charles Raymond Larkin Jr. serves as Independent Chairman of the Board of the Company. He has served as a director of Align since March 2004. In February 2006, Mr. Larkin was appointed as Chairman of the Board. He is currently a Principal of Group Outcome L.L.C., a merchant banking firm concentrating on medical technologies. From 2001 to 2007, he served as a part time Venture Partner at Cutlass Capital, a venture capital firm. Mr. Larkin was previously Chairman and Chief Executive Officer at Eunoe, Inc., a medical device company. From 1983 to March 1998, he held various executive positions with Nellcor Puritan Bennett, Inc., a medical instrumentation company, for which he served as President and Chief Executive Officer from 1989 until 1998. Mr. Larkin also held various positions of increasing responsibility at Bentley Laboratories/American Hospital Supply from 1976 to 1983. Since January 2019, he has been the Chairman of the Board of Shockwave Medical, a publicly traded cardiovascular technology business. He previously served on the board of directors of REVA Medical Inc., a medical device company developing and commercializing bioresorbable stents for the treatment of coronary artery disease and Heartware, Inc. prior to its acquisition by Medtronic, plc in 2017. Mr. Larkin received his B.S. in Industrial Management from LaSalle University.
As the Independent Chairman of the Board of Align Technology, the total compensation of Charles Larkin at Align Technology is $499,972. There are 10 executives at Align Technology getting paid more, with Joseph Hogan having the highest compensation of $18,269,100.
Charles Larkin is 71, he's been the Independent Chairman of the Board of Align Technology since 2006. There are no older and 30 younger executives at Align Technology.
C's mailing address filed with the SEC is C/O ALIGN TECHNOLOGY, INC., 410 N. SCOTTSDALE RD., SUITE 1300, TEMPE, AZ, 85288.
Over the last 22 years, insiders at Align Technology have traded over $1,465,859,191 worth of Align Technology stock and bought 2,715,224 units worth $38,925,222 . The most active insiders traders include Brian H Dovey, Kevin T Conroy a Corp /De/ Danaher. On average, Align Technology executives and independent directors trade stock every 11 days with the average trade being worth of $6,502,557. The most recent stock trade was executed by C Raymond Jr Larkin on 15 August 2024, trading 6,500 units of ALGN stock currently worth $1,529,645.
align technology is a global medical device company with industry-leading innovative products -- invisalign clear aligners and itero intraoral scanners -- that help dental professionals achieve the clinical results they expect and deliver effective, cutting-edge dental options to their patients. invisalign system invisalign clear aligners have been used to straighten teeth and treat minor to complex malocclusion for more than 3 million patients worldwide. the invisalign system is a combination of proprietary virtual modeling software and rapid mass-manufacturing processes used to develop a treatment plan and with custom-made aligners for each patient. invisalign is prescribed to patients through invisalign-trained orthodontists and general practitioner dentists (gp) and is offered in over 90 countries. learn more at www.invisalign.com itero intraoral scanner the itero scanner’s parallel confocal imaging technology uses optical and laser scanning to achieve a high level of precisi
Align Technology executives and other stock owners filed with the SEC include: